Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.31
-0.22 (-3.37%)
Apr 21, 2026, 1:11 PM EDT - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $467.49 million as of April 21, 2026. Its market cap has increased by 433.42% in one year.
Market Cap
467.49M
Enterprise Value
309.91M
1-Year Change
433.42%
Ranking
Category
Stock Price
$6.31
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $467.49M, an increase of 72.28%. That is a compound annual growth rate of 24.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 483.79M | -33.25% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 502.92M |
| Larimar Therapeutics | 499.68M |
| REGENXBIO | 488.82M |
| Entrada Therapeutics | 488.16M |
| MiMedx Group | 482.84M |
| Benitec Biopharma | 479.23M |
| XOMA Royalty | 476.63M |
| Invivyd | 475.11M |